Gene L. Bidwell, Ph.D. - Publications

Affiliations: 
2007 The University of Mississippi Medical Center, Jackson, MS, United States 
Area:
Cell Biology, Pharmacology

43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Mitra D, Hasan MH, Bates JT, Bidwell GL, Tandon R. Tegument Protein pp150 Sequence-Specific Peptide Blocks Cytomegalovirus Infection. Viruses. 13. PMID 34835083 DOI: 10.3390/v13112277  0.31
2020 Chade AR, Williams ML, Engel JE, Williams E, Bidwell GL. Molecular Targeting of Renal Inflammation using Drug Delivery Technology to Inhibit NF-kB Improves Renal Recovery in Chronic Kidney Disease. American Journal of Physiology. Renal Physiology. PMID 32538151 DOI: 10.1152/Ajprenal.00155.2020  0.325
2020 Akinleye AA, Burke S, Bidwell GL. Proximal Tubule Epithelial Cell Reabsorption of the Drug Delivery Protein Elastin‐like Polypeptide The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.09533  0.373
2020 Waller J, Burke S, Engel J, Chade A, Bidwell G. DETERMINING THE EFFECTS OF PRO‐ANGIOGENIC ELP‐VEGF THERAPY ON TUMOR GROWTH AND PROGRESSION The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.02219  0.339
2019 Eddy AC, Howell JA, Chapman H, Taylor E, Mahdi F, George EM, Bidwell GL. Biopolymer-Delivered, Maternally Sequestered NF-κB (Nuclear Factor-κB) Inhibitory Peptide for Treatment of Preeclampsia. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA11913. PMID 31786977 DOI: 10.1161/Hypertensionaha.119.13368  0.429
2019 Mahdi F, Chade AR, Bidwell GL. Utilizing a Kidney-Targeting Peptide to Improve Renal Deposition of a Pro-Angiogenic Protein Biopolymer. Pharmaceutics. 11. PMID 31635263 DOI: 10.3390/Pharmaceutics11100542  0.408
2018 Kuna M, Waller JP, Logue OC, Bidwell GL. Polymer size affects biodistribution and placental accumulation of the drug delivery biopolymer elastin-like polypeptide in a rodent pregnancy model. Placenta. 72: 20-27. PMID 30501877 DOI: 10.1016/J.Placenta.2018.10.005  0.337
2018 Kuna M, Mahdi F, Chade AR, Bidwell GL. Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide. Scientific Reports. 8: 7923. PMID 29784932 DOI: 10.1038/S41598-018-24897-9  0.308
2018 Bidwell G, Kuna M, Logue O, Eddy A, Chapman H, George E. 314. Maternally sequestered biologics for treatment of preeclampsia Pregnancy Hypertension. 13: S123. DOI: 10.1016/J.Preghy.2018.08.363  0.372
2016 Bidwell GL, Mahdi F, Shao Q, Logue OC, Waller JP, Reese C, Chade AR. A Kidney-selective Biopolymer for Targeted Drug Delivery. American Journal of Physiology. Renal Physiology. ajprenal.00143.2016. PMID 27784692 DOI: 10.1152/Ajprenal.00143.2016  0.391
2016 McGowan JW, Shao Q, Vig PJ, Bidwell GL. Intranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous system. Drug Design, Development and Therapy. 10: 2803-2813. PMID 27660412 DOI: 10.2147/Dddt.S106216  0.406
2016 Ilekis JV, Tsilou E, Fisher S, Abrahams VM, Soares MJ, Cross JC, Zamudio S, Illsley NP, Myatt L, Colvis C, Costantine MM, Haas DM, Sadovsky Y, Weiner C, Rytting E, ... Bidwell G, et al. Placental Origins of Adverse Pregnancy Outcomes: Potential Molecular Targets- An Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. American Journal of Obstetrics and Gynecology. PMID 26972897 DOI: 10.1016/J.Ajog.2016.03.001  0.353
2016 Chade AR, Vincent LJ, Bidwell GL. MO049A NOVEL BIOPOLYMER-DELIVERED VEGF FOR THERAPEUTIC ANGIOGENESIS IN RENOVASCULAR DISEASE: TARGETING THE KIDNEY VIA SYSTEMIC ADMINISTRATION Nephrology Dialysis Transplantation. 31: i50-i50. DOI: 10.1093/Ndt/Gfw139.01  0.328
2015 George EM, Mahdi F, Logue OC, Robinson GG, Bidwell GL. Corneal Penetrating Elastin-Like Polypeptide Carriers. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. PMID 26672799 DOI: 10.1089/jop.2015.0082  0.4
2015 McGowan JW, Bidwell GL, Vig PJ. Challenges and new strategies for therapeutic peptide delivery to the CNS. Therapeutic Delivery. 6: 841-53. PMID 26228775 DOI: 10.4155/Tde.15.30  0.455
2015 George EM, Liu H, Robinson GG, Mahdi F, Perkins E, Bidwell GL. Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis. Vascular Cell. 7: 1. PMID 25653833 DOI: 10.1186/S13221-014-0026-3  0.308
2015 Bidwell G, Reese C, Shao Q, Chade A. A Kidney-targeted Protein Biopolymer Drug Delivery System The Faseb Journal. 29. DOI: 10.1096/Fasebj.29.1_Supplement.967.5  0.344
2015 Bidwell GL, M. George E. [276-POS] Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health. 5: 138. DOI: 10.1016/J.Preghy.2014.10.282  0.451
2014 Bidwell GL, George EM. Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsia. Frontiers in Pharmacology. 5: 201. PMID 25249978 DOI: 10.3389/Fphar.2014.00201  0.428
2014 Lyons DF, Le V, Kramer WH, Bidwell GL, Lewis EA, Raucher D, Correia JJ. Effect of basic cell-penetrating peptides on the structural, thermodynamic, and hydrodynamic properties of a novel drug delivery vector, ELP[V5G3A2-150]. Biochemistry. 53: 1081-91. PMID 24450599 DOI: 10.1021/Bi400955W  0.697
2013 Lyons DF, Le V, Bidwell GL, Kramer WH, Lewis EA, Raucher D, Correia JJ. Structural and hydrodynamic analysis of a novel drug delivery vector: ELP[V5G3A2-150]. Biophysical Journal. 104: 2009-21. PMID 23663844 DOI: 10.1016/J.Bpj.2013.03.040  0.661
2013 Bidwell GL, Perkins E, Hughes J, Khan M, James JR, Raucher D. Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model. Plos One. 8: e55104. PMID 23372821 DOI: 10.1371/Journal.Pone.0055104  0.721
2013 Bidwell GL, Perkins E, Hughes J, Khan M, James JR, Raucher D. Biodistribution of CPP-ELPs Following IV Injection. Plos One. DOI: 10.1371/Journal.Pone.0055104.G002  0.569
2013 Lyons D, Le V, Bidwell GL, Kramer W, Lewis E, Raucher D, Correia JJ. Biophysical Analysis of a Novel Drug Delivery Vector: ELP[V5G3A2-150] Biophysical Journal. 104: 552a-553a. DOI: 10.1016/J.Bpj.2012.11.3065  0.631
2012 Tullos H, Dale B, Bidwell G, Perkins E, Raucher D, Khan M, James J. SU-E-I-67: Multi-Shot RESOLVE Compared to Single-Shot EPI Diffusion- Weighted MR Imaging Acquisition Scheme. Medical Physics. 39: 3640. PMID 28517668 DOI: 10.1118/1.4734783  0.506
2012 Bidwell GL. Peptides for cancer therapy: a drug-development opportunity and a drug-delivery challenge. Therapeutic Delivery. 3: 609-21. PMID 22834405 DOI: 10.4155/Tde.12.37  0.551
2012 Bidwell GL, Perkins E, Raucher D. A thermally targeted c-Myc inhibitory polypeptide inhibits breast tumor growth. Cancer Letters. 319: 136-43. PMID 22261328 DOI: 10.1016/J.Canlet.2011.12.042  0.719
2011 Bidwell GL, Perkins E, Raucher D. Abstract 4434: Thermally targeted delivery of a c-Myc inhibitory peptide to breast tumors in vivo using elastin-like polypeptide Cancer Research. 71: 4434-4434. DOI: 10.1158/1538-7445.Am2011-4434  0.699
2011 Lyons D, Bidwell GL, Kramer WH, Raucher D, Correia JJ. Biophysical Characterization of an Elastin-Like-Polypeptide Biophysical Journal. 100: 540a. DOI: 10.1016/J.Bpj.2010.12.3148  0.644
2010 Bidwell GL, Raucher D. Cell penetrating elastin-like polypeptides for therapeutic peptide delivery. Advanced Drug Delivery Reviews. 62: 1486-96. PMID 20478348 DOI: 10.1016/J.Addr.2010.05.003  0.754
2010 Bidwell GL, Whittom AA, Thomas E, Lyons D, Hebert MD, Raucher D. A thermally targeted peptide inhibitor of symmetrical dimethylation inhibits cancer-cell proliferation. Peptides. 31: 834-41. PMID 20167239 DOI: 10.1016/J.Peptides.2010.02.007  0.673
2010 Massodi I, Moktan S, Rawat A, Bidwell GL, Raucher D. Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier. International Journal of Cancer. 126: 533-44. PMID 19588502 DOI: 10.1002/Ijc.24725  0.761
2010 Bidwell GL, Hughes J, Perkins E, Raucher D. Abstract 5516: A cell penetrating c-Myc inhibitory polypeptide accumulates in brain tumors in rats and inhibits tumor growth Cancer Research. 70: 5516-5516. DOI: 10.1158/1538-7445.Am10-5516  0.714
2009 Raucher D, Moktan S, Massodi I, Bidwell GL. Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides. Expert Opinion On Drug Delivery. 6: 1049-64. PMID 19743895 DOI: 10.1517/17425240903158909  0.75
2009 Bidwell GL, Raucher D. Therapeutic peptides for cancer therapy. Part I - peptide inhibitors of signal transduction cascades. Expert Opinion On Drug Delivery. 6: 1033-47. PMID 19637980 DOI: 10.1517/17425240903143745  0.728
2009 Massodi I, Bidwell GL, Davis A, Tausend A, Credit K, Flessner M, Raucher D. Inhibition of ovarian cancer cell metastasis by a fusion polypeptide Tat-ELP. Clinical & Experimental Metastasis. 26: 251-60. PMID 19169893 DOI: 10.1007/S10585-009-9237-Z  0.763
2009 Bidwell GL, Davis AN, Raucher D. Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides. Journal of Controlled Release : Official Journal of the Controlled Release Society. 135: 2-10. PMID 19095020 DOI: 10.1016/j.jconrel.2008.11.015  0.712
2008 Raucher D, Massodi I, Bidwell GL. Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide. Expert Opinion On Drug Delivery. 5: 353-69. PMID 18318656 DOI: 10.1517/17425247.5.3.353  0.793
2007 Bidwell GL, Davis AN, Fokt I, Priebe W, Raucher D. A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance. Investigational New Drugs. 25: 313-26. PMID 17483874 DOI: 10.1007/S10637-007-9053-8  0.641
2007 Bidwell GL, Fokt I, Priebe W, Raucher D. Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin. Biochemical Pharmacology. 73: 620-31. PMID 17161827 DOI: 10.1016/J.Bcp.2006.10.028  0.716
2006 Bidwell GL, Raucher D. Enhancing the antiproliferative effect of topoisomerase II inhibitors using a polypeptide inhibitor of c-Myc. Biochemical Pharmacology. 71: 248-56. PMID 16316634 DOI: 10.1016/J.Bcp.2005.10.041  0.667
2005 Massodi I, Bidwell GL, Raucher D. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 108: 396-408. PMID 16157413 DOI: 10.1016/J.Jconrel.2005.08.007  0.792
2005 Bidwell GL, Raucher D. Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy. Molecular Cancer Therapeutics. 4: 1076-85. PMID 16020665 DOI: 10.1158/1535-7163.Mct-04-0253  0.696
Show low-probability matches.